Patents/Inventors

Bernd Zetsche

Cambridge, MAUS25 patents

17 Patents

US126009712026
Modified Immune Cells Having Adenosine Deaminase Base Editors for Modifying a Nucleobase in a Target Sequence
BEAM THERAPEUTICS Inc.
0 cites
US125954782026
Crispr-cas Systems Having Destabilization Domain
The Brigham And Women's Hospital, Inc.
0 cites
US124353202025
CRISPR Having or Associated with Destabilization Domains
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
0 cites
US124104682025
CRISPR Enzymes and Systems
PRESIDENT AND FELLOWS OF HARVARD COLLEAGE
0 cites
US124104162025
CRISPR Enzymes and Systems with Modified Pam Specificity
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
0 cites
US123717372025
CRISPR Enzymes and Systems
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
0 cites
US123448382025
CPF1 Complexes with Reduced Indel Activity
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
0 cites
US122643592025
CRISPR Enzymes and Systems
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
0 cites
US121230322024
CRISPR Enzyme Mutations Reducing Off-target Effects
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
0 cites
US121104902024
CRISPR Enzymes and Systems
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
0 cites
US120917092024
Crispr Enzymes and Systems
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
0 cites
US120169082024
Compositions and Methods for Treating Hemoglobinopathies
Beam Therapeutics Inc.
0 cites
US118666972024
Systems, Methods, and Compositions for Targeted Nucleic Acid Editing
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
0 cites
US117811722023
Crispr Enzymes and Systems
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
0 cites
US117734322023
CRISPR Enzymes and Systems
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
0 cites
US117522022023
Compositions and Methods for Treating Hemoglobinopathies
Beam Therapeutics Inc.
0 cites
US116347552023
Crispr Enzymes and Systems
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
0 cites